Literature DB >> 1385722

Peripheral tolerance through clonal deletion of mature CD4-CD8+ T cells.

D A Carlow1, S J Teh, N S van Oers, R G Miller, H S Teh.   

Abstract

Transgenic mice bearing the alpha beta transgenes encoding a defined T cell receptor specific for the male (H-Y) antigen presented by the H-2Db class I MHC molecule were used to study mechanisms of peripheral tolerance. Female transgenic mice produce large numbers of functionally homogeneous CD8+ male antigen-reactive T cells in the thymus that subsequently accumulate in the peripheral lymphoid organs. We have used three experimental approaches to show that male reactive CD8+ T cells can be eliminated from peripheral lymphoid organs after exposure to male antigen. (i) In female transgenic mice that were neonatally tolerized with male spleen cells, male reactive CD8+ T cells continued to be produced in large numbers in the thymus but were virtually absent in the lymph nodes. (ii) Injection of thymocytes from female transgenic mice into female mice neonatally tolerized with the male antigen, or into normal male mice, led to the specific elimination of male-reactive CD8+ T cells in the lymph nodes. (iii) Four days after male lymphoid cells were injected intravenously into female transgenic mice, male antigen-reactive CD8+ T cells recovered from the lymph nodes of recipient mice were highly apoptotic when compared to CD4+ (non-male reactive) T cells. These data indicate that tolerance to extrathymic antigen can be achieved through elimination of mature T cells in the peripheral lymphoid organs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385722     DOI: 10.1093/intimm/4.5.599

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  11 in total

Review 1.  Function of Act1 in IL-17 family signaling and autoimmunity.

Authors:  Ling Wu; Jarod Zepp; Xiaoxia Li
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 2.  Mechanisms of self-nonself discrimination and possible clinical relevance.

Authors:  Carolin Daniel; Jens Nolting; Harald von Boehmer
Journal:  Immunotherapy       Date:  2009-07       Impact factor: 4.196

3.  Modulation of superantigen-induced T-cell deletion by antibody anti-Pgp-1 (CD44).

Authors:  E Ayroldi; L Cannarile; C Ricardi
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

4.  T-bet down-modulation in tolerized Th1 effector CD4 cells confers a TCR-distal signaling defect that selectively impairs IFN-gamma expression.

Authors:  Meixiao Long; Aaron M Slaiby; Adam T Hagymasi; Marianne A Mihalyo; Alexander C Lichtler; Steven L Reiner; Adam J Adler
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

5.  Programmed cell death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency.

Authors:  E S Razvi; R M Welsh
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

6.  Dexamethasone induces apoptosis in mouse natural killer cells and cytotoxic T lymphocytes.

Authors:  G Migliorati; I Nicoletti; F D'Adamio; A Spreca; C Pagliacci; C Riccardi
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

7.  CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells.

Authors:  A J Adler; D W Marsh; G S Yochum; J L Guzzo; A Nigam; W G Nelson; D M Pardoll
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

8.  Unresponsiveness to a self-peptide of mouse lysozyme owing to hindrance of T cell receptor-major histocompatibility complex/peptide interaction caused by flanking epitopic residues.

Authors:  K D Moudgil; I S Grewal; P E Jensen; E E Sercarz
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

9.  Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance.

Authors:  B Rocha; A Grandien; A A Freitas
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

10.  T cell and non-T cell compartments can independently determine resistance to Leishmania major.

Authors:  A H Shankar; R G Titus
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.